Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of In-Vitro Cancer Diagnostics
1.2 Key Market Segments
1.2.1 In-Vitro Cancer Diagnostics Segment by Type
1.2.2 In-Vitro Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 In-Vitro Cancer Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global In-Vitro Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global In-Vitro Cancer Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 In-Vitro Cancer Diagnostics Market Competitive Landscape
3.1 Global In-Vitro Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global In-Vitro Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers In-Vitro Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 In-Vitro Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 In-Vitro Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest In-Vitro Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 In-Vitro Cancer Diagnostics Industry Chain Analysis
4.1 In-Vitro Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of In-Vitro Cancer Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 In-Vitro Cancer Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global In-Vitro Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global In-Vitro Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global In-Vitro Cancer Diagnostics Price by Type (2019-2024)
7 In-Vitro Cancer Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global In-Vitro Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global In-Vitro Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global In-Vitro Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 In-Vitro Cancer Diagnostics Market Segmentation by Region
8.1 Global In-Vitro Cancer Diagnostics Sales by Region
8.1.1 Global In-Vitro Cancer Diagnostics Sales by Region
8.1.2 Global In-Vitro Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America In-Vitro Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe In-Vitro Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific In-Vitro Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America In-Vitro Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa In-Vitro Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 MDx Health Quest Diagnostics
9.1.1 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Basic Information
9.1.2 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Overview
9.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Market Performance
9.1.4 MDx Health Quest Diagnostics Business Overview
9.1.5 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics SWOT Analysis
9.1.6 MDx Health Quest Diagnostics Recent Developments
9.2 R-Biopharm AG
9.2.1 R-Biopharm AG In-Vitro Cancer Diagnostics Basic Information
9.2.2 R-Biopharm AG In-Vitro Cancer Diagnostics Product Overview
9.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Product Market Performance
9.2.4 R-Biopharm AG Business Overview
9.2.5 R-Biopharm AG In-Vitro Cancer Diagnostics SWOT Analysis
9.2.6 R-Biopharm AG Recent Developments
9.3 Signature Diagnostics
9.3.1 Signature Diagnostics In-Vitro Cancer Diagnostics Basic Information
9.3.2 Signature Diagnostics In-Vitro Cancer Diagnostics Product Overview
9.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Product Market Performance
9.3.4 Signature Diagnostics In-Vitro Cancer Diagnostics SWOT Analysis
9.3.5 Signature Diagnostics Business Overview
9.3.6 Signature Diagnostics Recent Developments
9.4 Siemens Healthcare
9.4.1 Siemens Healthcare In-Vitro Cancer Diagnostics Basic Information
9.4.2 Siemens Healthcare In-Vitro Cancer Diagnostics Product Overview
9.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Product Market Performance
9.4.4 Siemens Healthcare Business Overview
9.4.5 Siemens Healthcare Recent Developments
9.5 Randox Laboratories
9.5.1 Randox Laboratories In-Vitro Cancer Diagnostics Basic Information
9.5.2 Randox Laboratories In-Vitro Cancer Diagnostics Product Overview
9.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Product Market Performance
9.5.4 Randox Laboratories Business Overview
9.5.5 Randox Laboratories Recent Developments
9.6 Epigenomics AG
9.6.1 Epigenomics AG In-Vitro Cancer Diagnostics Basic Information
9.6.2 Epigenomics AG In-Vitro Cancer Diagnostics Product Overview
9.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Product Market Performance
9.6.4 Epigenomics AG Business Overview
9.6.5 Epigenomics AG Recent Developments
9.7 Beckman Coulter
9.7.1 Beckman Coulter In-Vitro Cancer Diagnostics Basic Information
9.7.2 Beckman Coulter In-Vitro Cancer Diagnostics Product Overview
9.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Product Market Performance
9.7.4 Beckman Coulter Business Overview
9.7.5 Beckman Coulter Recent Developments
9.8 Abbott Laboratories
9.8.1 Abbott Laboratories In-Vitro Cancer Diagnostics Basic Information
9.8.2 Abbott Laboratories In-Vitro Cancer Diagnostics Product Overview
9.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Product Market Performance
9.8.4 Abbott Laboratories Business Overview
9.8.5 Abbott Laboratories Recent Developments
9.9 Burning Rock
9.9.1 Burning Rock In-Vitro Cancer Diagnostics Basic Information
9.9.2 Burning Rock In-Vitro Cancer Diagnostics Product Overview
9.9.3 Burning Rock In-Vitro Cancer Diagnostics Product Market Performance
9.9.4 Burning Rock Business Overview
9.9.5 Burning Rock Recent Developments
9.10 Novogene
9.10.1 Novogene In-Vitro Cancer Diagnostics Basic Information
9.10.2 Novogene In-Vitro Cancer Diagnostics Product Overview
9.10.3 Novogene In-Vitro Cancer Diagnostics Product Market Performance
9.10.4 Novogene Business Overview
9.10.5 Novogene Recent Developments
9.11 Geneseeq
9.11.1 Geneseeq In-Vitro Cancer Diagnostics Basic Information
9.11.2 Geneseeq In-Vitro Cancer Diagnostics Product Overview
9.11.3 Geneseeq In-Vitro Cancer Diagnostics Product Market Performance
9.11.4 Geneseeq Business Overview
9.11.5 Geneseeq Recent Developments
9.12 Amoy Diagnostics Co.,Ltd.
9.12.1 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Basic Information
9.12.2 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Overview
9.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Market Performance
9.12.4 Amoy Diagnostics Co.,Ltd. Business Overview
9.12.5 Amoy Diagnostics Co.,Ltd. Recent Developments
9.13 Daan Gene
9.13.1 Daan Gene In-Vitro Cancer Diagnostics Basic Information
9.13.2 Daan Gene In-Vitro Cancer Diagnostics Product Overview
9.13.3 Daan Gene In-Vitro Cancer Diagnostics Product Market Performance
9.13.4 Daan Gene Business Overview
9.13.5 Daan Gene Recent Developments
9.14 Fosun Pharma
9.14.1 Fosun Pharma In-Vitro Cancer Diagnostics Basic Information
9.14.2 Fosun Pharma In-Vitro Cancer Diagnostics Product Overview
9.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Product Market Performance
9.14.4 Fosun Pharma Business Overview
9.14.5 Fosun Pharma Recent Developments
10 In-Vitro Cancer Diagnostics Market Forecast by Region
10.1 Global In-Vitro Cancer Diagnostics Market Size Forecast
10.2 Global In-Vitro Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe In-Vitro Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific In-Vitro Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America In-Vitro Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of In-Vitro Cancer Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global In-Vitro Cancer Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of In-Vitro Cancer Diagnostics by Type (2025-2030)
11.1.2 Global In-Vitro Cancer Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of In-Vitro Cancer Diagnostics by Type (2025-2030)
11.2 Global In-Vitro Cancer Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global In-Vitro Cancer Diagnostics Sales (Kilotons) Forecast by Application
11.2.2 Global In-Vitro Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
